Nanoviricides Overview

  • Founded
  • 2005

Founded
  • Status
  • Public

  • Employees
  • 17

Employees
  • Stock Symbol
  • NNVC

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $2.78

  • (As of Friday Closing)

Nanoviricides General Information

Description

Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
ASE
Primary Office
  • 1 Controls Drive
  • Suite 205
  • Shelton, CT 06484
  • United States
+1 (203) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanoviricides Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.78 $2.65 $1.04 - $7.86 $32.1M 11.6M 609K -$0.73

Nanoviricides Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019
EV 6,771 30,650 62,942 14,185
Revenue 0 0 0 0
EBITDA (7,684) (8,042) (12,670) (7,784)
Net Income (8,400) (8,822) (13,447) (8,424)
Total Assets 25,145 30,262 23,914 13,449
Total Debt 165 95 1,145 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Nanoviricides Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nanoviricides‘s full profile, request access.

Request a free trial

Nanoviricides Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing t
Biotechnology
Shelton, CT
17 As of 2021
000.00
000000000 000.00

000000

o consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
0000 000000000
Hannover, Germany
00 As of 0000
00000
00000000000 00000

000000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culp
0000 000000000
Bothell, WA
0000 As of 0000
00.000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Nanoviricides Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardior Venture Capital-Backed Hannover, Germany 00 00000 00000000000 00000
000000 Formerly VC-backed Bothell, WA 0000 00.000 000000&0
00000000 000000000 Corporation Gaithersburg, MD 0000 00000 000000000 00000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000000 00.000
0000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
You’re viewing 5 of 29 competitors. Get the full list »

Nanoviricides Executive Team (4)

Name Title Board Seat Contact Info
Anil Diwan Ph.D Chief Executive Officer & Chairman
Meeta Vyas Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
You’re viewing 2 of 4 executive team members. Get the full list »

Nanoviricides Board Members (5)

Name Representing Role Since
0000 00000 00.0 Nanoviricides Chief Executive Officer & Chairman 000 0000
0000 000 00.0 Nanoviricides Board Member 000 0000
0000 000000 Nanoviricides Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Nanoviricides Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanoviricides Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nanoviricides‘s full profile, request access.

Request a free trial

Nanoviricides Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000-00000 (0 07-Jan-2015 000000000 Buildings and Property 000000 00
Edot-com.com 01-Jun-2005 Merger/Acquisition Internet Retail 000000 00
To view Nanoviricides’s complete investments and acquisitions history, request access »